Table 2.
SP-B peptide | CON |
RDS |
||
---|---|---|---|---|
AD (n = 5) | ED (n = 21) | AD (n = 14) | ED (n = 61) | |
M42 | 2 | 7 | ||
M40 | 1* | 4 | 3 | 8 |
M38 | 1 | 1 | ||
M36 | 2 | |||
M34 | 1 | 1 | 1 | 2 |
M32 | 1 | 3 | 3 | |
M30 | 1 | 2 | ||
M29 | 2 | 3 | ||
M28 | 2 | 3 | 12 | |
M27 | 1 | 2 | 8 | |
M26 | 1 | 1 | 3 | |
M25 | 2 | 1 | 3 | |
M24 | 2 | 15 | 10 | 55 |
M23 | 1 | 6 | ||
M22 | 1 | |||
M21 | 5 | 21 | 9 | 44 |
M19 | ||||
M17 | 1 | 1 | 4 | |
M16 | 1 | 5 | ||
M15 | 1 | 1 | 2 | |
M14 | 1 | 1 | 1 | |
M13 | 1 | 1 | ||
P42 | 1 | 6 | 6 | 28 |
P40 | 2 | 10 | 7 | 26 |
P36 | 1 | |||
P28 | 2 | |||
P27 | 1 | |||
P26 | 1 | |||
P25 | 2 | 1 | ||
P24 | 4 | 21 | 14 | 59 |
P21 | 1 | 1 | ||
P20 | 1 | 2 | 15 | |
P19 | 1 | 2 | 2 | 18 |
P18 | 1 | 2 | ||
P17 | 5 | 13 | 3 | 28 |
P16 | 1 | 1 | 2 | |
P15 | 3 | 14 | 8 | 39 |
P13 | 1 | 1 | ||
P12 | 1 | 3 | ||
P11 | 1 | 2 | 4 | |
P10 | 2 |
SP-B peptides are designated by M (detected by antibody to mature SP-B) or P (detected by antibody to pro-SP-B) and their molecular mass (Mr) in kDa.
CON = Control infants;
RDS = RDS infants;
AD = African descent;
ED = European descent.
* Denotes number of individuals with each peptide.